Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 155 of the 157 references it cites were found in a registry or an index.

Atopic dermatitis

Abstract

Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. Although it most often starts in infancy and affects two of ten children, it is also highly prevalent in adults. It is the leading non-fatal health burden attributable to skin diseases, inflicts a substantial psychosocial burden on patients and their relatives, and increases the risk of food allergy, asthma, allergic rhinitis, other immune-mediated inflammatory diseases, and mental health disorders. Originally regarded as a childhood disorder mediated by an imbalance towards a T-helper-2 response and exaggerated IgE responses to allergens, it is now recognised as a lifelong disposition with variable clinical manifestations and expressivity, in which defects of the epidermal barrier are central. Present prevention and treatment focus on restoration of epidermal barrier function, which is best achieved through the use of emollients. Topical corticosteroids are still the first-line therapy for acute flares, but they are also used proactively along with topical calcineurin inhibitors to maintain remission. Non-specific immunosuppressive drugs are used in severe refractory cases, but targeted disease-modifying drugs are being developed. We need to improve understanding of the heterogeneity of the disease and its subtypes, the role of atopy and autoimmunity, the mechanisms behind disease-associated itch, and the comparative effectiveness and safety of therapies.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)00149-x

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 157 references

Research works printed but not linked: 2

  1. Paternoster L, Standl M, Waage J, et al. Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet (in press).
  2. Reuter, 2010, Botanicals in dermatology: an evidence-based review, Am J Clin Dermatol, 11, 247

Cited by

See all 1,908

Metadata

Authors
Weidinger, S., & Novak, N.
Affiliations
  • University Hospital Schleswig-Holstein (DE)
  • University Hospital Bonn (DE)
Corresponding author
Weidinger, Stephan
Venue
The Lancet
Publisher
Elsevier BV
Published
2016-03
Volume
387
Issue
10023
Pages
1109-1122
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4211145137
Cited by
1,908
References
157
Citations by year
2026: 171 · 2025: 169 · 2024: 207 · 2023: 180 · 2022: 210 · 2021: 224 · 2020: 198 · 2019: 193 · 2018: 170 · 2017: 121 · 2016: 64
FWCI
18.91
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
  • Christine Kühne – Center for Allergy Research and Education
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
atopic dermatitis, skin barrier dysfunction, emollients, topical corticosteroids, topical calcineurin inhibitors, immunosuppressive therapy, disease-modifying therapy, T helper 2 response, IgE, atopy, autoimmunity, pruritus, disease heterogeneity, comorbidities, psychosocial burden, treatment effectiveness and safety
MeSH terms
Adult, Child, Dermatitis, Atopic, Dermatologic Agents, Humans, Infant, Risk Factors, Global Health, Prevalence, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Atopic dermatitis. https://app.cochat.ai/papers/10.1016/s0140-6736(15)00149-x
The paper
Weidinger, S., & Novak, N. (2016). Atopic dermatitis. The Lancet. https://doi.org/10.1016/s0140-6736(15)00149-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.